The DOI matches its Crossref record; 210 of the 211 references it cites were found in a registry or an index.
The tubular hypothesis of nephron filtration and diabetic kidney disease
Open accessAbstract
Kidney size and glomerular filtration rate (GFR) often increase with the onset of diabetes, and elevated GFR is a risk factor for the development of diabetic kidney disease. Hyperfiltration mainly occurs in response to signals passed from the tubule to the glomerulus: high levels of glucose in the glomerular filtrate drive increased reabsorption of glucose and sodium by the sodium-glucose cotransporters SGLT2 and SGLT1 in the proximal tubule. Passive reabsorption of chloride and water also increases. The overall capacity for proximal reabsorption is augmented by growth of the proximal tubule, which (alongside sodium-glucose cotransport) further limits urinary glucose loss. Hyperreabsorption of sodium and chloride induces tubuloglomerular feedback from the macula densa to increase GFR. In addition, sodium-glucose cotransport by SGLT1 on macula densa cells triggers the production of nitric oxide, which also contributes to glomerular hyperfiltration. Although hyperfiltration restores sodium and chloride excretion it imposes added physical stress on the filtration barrier and increases the oxygen demand to drive reabsorption. Tubular growth is associated with the development of a senescence-like molecular signature that sets the stage for inflammation and fibrosis. SGLT2 inhibitors attenuate the proximal reabsorption of sodium and glucose, normalize tubuloglomerular feedback signals and mitigate hyperfiltration. This tubule-centred model of diabetic kidney physiology predicts the salutary effect of SGLT2 inhibitors on hard renal outcomes, as shown in large-scale clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a paracrine manner, adenosine constricts the afferent arteriole through the adenosine 1 receptor, thereby decreasing glomerular perfusion and hyperfiltration, a central mechanism for progressive glomerular injury (21,22).”
From SGLT2 inhibition for CKD and cardiovascular disease in type 2 diabetes: report of a scientific workshop sponsored by the National Kidney Foundation (2021) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
Zelniker, T. A., Wiviott, S. D., Raz, I., Im, K., Goodrich, E. L., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Furtado, R. H. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32590-x · Cited by 2,845
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
Saran, R., Robinson, B. M., Abbott, K. C., Agodoa, L. Y. C., Albertus, P., Ayanian, J. Z., Balkrishnan, R., Bragg‐Gresham, J. L., Cao, J., Chen, J. L. T., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.004 · Cited by 2,192
Biology of Human Sodium Glucose Transporters
Wright, E. M., Loo, D. D. F., & Hirayama, B. A. (2011) · Physiological Reviews · doi:10.1152/physrev.00055.2009 · Cited by 1,430
Thomas, M. C., Brownlee, M., Suszták, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P. R., Groop, P., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,335
Cherney, D. Z. I., Perkins, B. A., Soleymanlou, N., Maione, M., Lai, V., Lee, A., Fagan, N. M., Woerle, H. J., Johansen, O. E., Broedl, U. C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005081 · Cited by 1,329
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Ferrannini, E., Muscelli, E., Frascerra, S., Baldi, S., Mari, A., Heise, T., Broedl, U. C., & Woerle, H.-J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72227 · Cited by 1,134
The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy
Mogensen, C. E., Christensen, C., & Vittinghus, E. (1983) · Diabetes · doi:10.2337/diab.32.2.s64 · Cited by 982
CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
Ferrannini, E., Mark, M., & Mayoux, E. (2016) · Diabetes Care · doi:10.2337/dc16-0330 · Cited by 975
Blood Pressure Control—Special Role of the Kidneys and Body Fluids
Guyton, A. C. (1991) · Science · doi:10.1126/science.2063193 · Cited by 966
Molecular mechanisms of diabetic kidney disease
Reidy, K. J., Kang, H. M., Hostetter, T. H., & Suszták, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72271 · Cited by 929
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., de la Cruz, M. D. C. I., Hong, S. W., Isono, M., Chen, S., McGowan, T., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Bommel, E. J., Heerspink, H. J. L., van Raalte, D. H., & Joles, J. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060666 · Cited by 887
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
Lambers Heerspink, H. J., de Zeeuw, D., Wie, L., Leslie, B., & List, J. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12127 · Cited by 837
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
Merovci, A., Solis-Herrera, C., Daniele, G., Eldor, R., Fiorentino, T. V., Tripathy, D., Xiong, J., Perez, Z., Norton, L., Abdul-Ghani, M. A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70704 · Cited by 795
Rahmoune, H., Thompson, P. W., Ward, J. M., Smith, C. D., Hong, G., & Brown, J. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3427 · Cited by 787
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092150 · Cited by 780
Inzucchi, S. E., Zinman, B., Fitchett, D., Wanner, C., Ferrannini, E., Schumacher, M., Schmoor, C., Ohneberg, K., Johansen, O. E., George, J. T., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1096 · Cited by 740
Gorboulev, V., Schürmann, A., Vallon, V., Kipp, H., Jaschke, A., Klessen, D., Friedrich, A., Scherneck, S., Rieg, T., Cunard, R., et al. (2012) · Diabetes · doi:10.2337/db11-1029 · Cited by 687
Self-citationVallon, V., & Thomson, S. C. (2017) · Diabetologia · doi:10.1007/s00125-016-4157-3 · Cited by 635
Self-citationKramer, H. J. (2003) · JAMA · doi:10.1001/jama.289.24.3273 · Cited by 618
Barnett, A. H., Mithal, A., Manassie, J., Jones, R., Rattunde, H., Woerle, H. J., & Broedl, U. C. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70208-0 · Cited by 584
SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule
Vallon, V., Platt, K. A., Cunard, R. A., Schroth, J., Whaley, J. M., Thomson, S. C., Koepsell, H., & Rieg, T. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010030246 · Cited by 565
Self-citationEffect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus
Kato, E. T., Silverman, M. G., Mosenzon, O., Zelniker, T. A., Cahn, A., Furtado, R. H. M., Kuder, J., Murphy, S. A., Bhatt, D. L., Leiter, L. A., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040130 · Cited by 557
Diabetic kidney disease: world wide difference of prevalence and risk factors.
Gheith, O. A. A., Othman, N. F., Nampoory, N., Halim, M. A., & Al-Otaibi, T. (2016) · Europe PMC (PubMed Central) · Cited by 525
Nitric oxide synthase in macula densa regulates glomerular capillary pressure.
Wilcox, C. S., Welch, W. J., Murad, F., Gross, S. S., Taylor, G., Levi, R. C., & Schmidt, H. H. H. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11993 · Cited by 520
Sugar Absorption in the Intestine: The Role of GLUT2
Kellett, G. L., Brot‐Laroche, E., Mace, O. J., & Leturque, A. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155518 · Cited by 503
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
Yale, J., Bakris, G. L., Cariou, B., Yue, D. K., David‐Neto, E., Xi, L., Figueroa, K., Wajs, E., Usiskin, K., & Meininger, G. E. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12090 · Cited by 485
Vallon, V., Gerasimova, M., Rose, M. A., Masuda, T., Satriano, J., Mayoux, E., Koepsell, H., Thomson, S. C., & Rieg, T. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00520.2013 · Cited by 483
Self-citationMolecular mechanisms of diabetic renal hypertrophy
Wolf, G., & Ziyadeh, F. N. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00590.x · Cited by 467
Vallon, V., Mühlbauer, B., & Oßwald, H. (2006) · Physiological Reviews · doi:10.1152/physrev.00031.2005 · Cited by 450
Self-citationUric acid in metabolic syndrome: From an innocent bystander to a central player
Kanbay, M., Jensen, T., Solak, Y., Le, M., Roncal-Jimenez, C., Rivard, C., Lanaspa, M. A., Nakagawa, T., & Johnson, R. J. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.11.026 · Cited by 419
Nonalbuminuric Renal Insufficiency in Type 2 Diabetes
MacIsaac, R. J., Tsalamandris, C., Panagiotopoulos, S., Smith, T. J., McNeil, K. J., & Jerums, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.195 · Cited by 410
The proximal tubule in the pathophysiology of the diabetic kidney
Vallon, V. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00809.2010 · Cited by 399
Self-citationProbing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences
Gallo, L. A., Wright, E. M., & Vallon, V. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114561992 · Cited by 395
Self-citationChino, Y., Samukawa, Y., Sakai, S., Nakai, Y., Yamaguchi, J., Nakanishi, T., & Tamai, I. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1909 · Cited by 390
Lanting, L. C., Joung, I. M. A., Mackenbach, J. P., Lamberts, S. W. J., & Bootsma, A. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2280 · Cited by 386
Pathogenesis of the Podocytopathy and Proteinuria in Diabetic Glomerulopathy
Ziyadeh, F. N., & Wolf, G. (2008) · Current Diabetes Reviews · doi:10.2174/157339908783502370 · Cited by 383
Development of SGLT1 and SGLT2 inhibitors
Rieg, T., & Vallon, V. (2018) · Diabetologia · doi:10.1007/s00125-018-4654-7 · Cited by 377
Self-citationVallon, V., & Thomson, S. C. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153333 · Cited by 376
Self-citationVallon, V., Rose, M., Gerasimova, M., Satriano, J., Platt, K. A., Koepsell, H., Cunard, R., Sharma, K., Thomson, S. C., & Rieg, T. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00409.2012 · Cited by 370
Self-citationHoltkamp, F. A., de Zeeuw, D., Thomas, M. C., Cooper, M. E., de Graeff, P. A., Hillege, H. J. L., Parving, H.-H., Brenner, B. M., Shahinfar, S., & Lambers Heerspink, H. J. (2011) · Kidney International · doi:10.1038/ki.2011.79 · Cited by 364
Mitochondrial Pathology and Glycolytic Shift during Proximal Tubule Atrophy after Ischemic AKI
Lan, R., Geng, H. Z., Singha, P. K., Saikumar, P., Böttinger, E. P., Weinberg, J. M., & Venkatachalam, M. A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015020177 · Cited by 364
The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
Vallon, V. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-051013-110046 · Cited by 363
Self-citationCanagliflozin slows progression of renal function decline independently of glycemic effects
Heerspink, H. J. L., Desai, M., Jardine, M., Balis, D., Meininger, G., & Perkovic, V. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016030278 · Cited by 361
Glomerular Hyperfiltration in Experimental Diabetes Mellitus
Vallon, V., Richter, K., Blantz, R. C., Thomson, S. C., & Oßwald, H. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10122569 · Cited by 356
Self-citationMagee, G., Bilous, R., Cardwell, C., Hunter, S., Kee, F., & Fogarty, D. (2009) · Diabetologia · doi:10.1007/s00125-009-1268-0 · Cited by 349
Thomas, M. C., Moran, J., Forsblom, C., Harjutsalo, V., Thorn, L., Ahola, A., Wadén, J., Tolonen, N., Saraheimo, M., Gordin, D., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1722 · Cited by 349
Familial Renal Glucosuria and SGLT2
Santer, R., & Calado, J. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04010609 · Cited by 347
Thomson, S. C., Rieg, T., Miracle, C. M., Mansoury, H., Whaley, J. M., Vallon, V., & Singh, P. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00357.2011 · Cited by 316
Self-citationRieg, T., Masuda, T., Gerasimova, M., Mayoux, E., Platt, K. A., Powell, D. R., Thomson, S. C., Koepsell, H., & Vallon, V. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00518.2013 · Cited by 313
Self-citationDietary salt intake and mortality in patients with type 2 diabetes
Ekinci, E. I., Clarke, S., Thomas, M. C., Moran, J. L., Cheong, K., MacIsaac, R. J., & Jerums, G. (2011) · Diabetes Care · doi:10.2337/dc10-1723 · Cited by 309
SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy
Wang, X. X., Levi, J., Luo, Y., Myakala, K., Herman‐Edelstein, M., Qiu, L., Wang, D., Peng, Y., Grenz, A., Lucia, S. M., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.779520 · Cited by 307
Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy
Verzola, D., Gandolfo, M. T., Gaetani, G., Ferraris, A., Mangerini, R., Ferrario, F., Villaggio, B., Gianiorio, F., Tosetti, F., Weiss, U., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90302.2008 · Cited by 302
DeFronzo, R. A., Hompesch, M., Kasichayanula, S., Liu, X., Hong, Y., Pfister, M., Morrow, L. A., Leslie, B. R., Boulton, D. W., Ching, A., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0387 · Cited by 293
Vrhovac, I., Balen, D., Klessen, D., Burger, C., Breljak, D., Kraus, O., Radović, N., Jadrijević, S., Aleksić, I., Walles, T., et al. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1619-7 · Cited by 292
Pathophysiology of the Diabetic Kidney
Vallon, V., & Komers, R. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100049 · Cited by 291
Self-citationA role for AMP-activated protein kinase in diabetes-induced renal hypertrophy
Lee, M.-J., Féliers, D., Mariappan, M. M., Sataranatarajan, K., Mahimainathan, L., Musi, N., Foretz, M., Viollet, B., Weinberg, J. M., Choudhury, G. G., et al. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00278.2006 · Cited by 287
Monami, M., Nardini, C., & Mannucci, E. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12244 · Cited by 286
Kidokoro, K., Cherney, D. Z. I., Bozovic, A., Nagasu, H., Satoh, M., Kanda, E., Sasaki, T., & Kashihara, N. (2019) · Circulation · doi:10.1161/circulationaha.118.037418 · Cited by 283
Martı́n, M. G., Turk, E., Lostao, M. P., Kerner, C. J., & Wright, E. M. (1996) · Nature Genetics · doi:10.1038/ng0296-216 · Cited by 275
Glomerular endothelial cell injury and cross talk in diabetic kidney disease
Fu, J., Lee, K., Chuang, P. Y., Liu, Z., & He, C. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00533.2014 · Cited by 267
Sano, M., Takei, M., Shiraishi, Y., & Suzuki, Y. (2016) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2760w · Cited by 254
Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential
Yang, D., Livingston, M. J., Liu, Z., Dong, G., Zhang, M., Chen, J.-K., & Dong, Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2639-1 · Cited by 252
Kidney function in early diabetes: the tubular hypothesis of glomerular filtration
Thomson, S. C., Vallon, V., & Blantz, R. C. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00208.2003 · Cited by 241
Self-citationThomson, S. C., Deng, A., Bao, D., Satriano, J. A., Blantz, R. C., & Vallon, V. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10963 · Cited by 236
Self-citationO’Neill, J., Fasching, A., Pihl, L., Patinha, D., Franzén, S., & Palm, F. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00689.2014 · Cited by 234
Qiu, H., Novikov, A., & Vallon, V. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2886 · Cited by 227
Self-citationMogensen, C. E. (1971) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517109090668 · Cited by 222
SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function
Jurczak, M. J., Lee, H., Birkenfeld, A. L., Jornayvaz, F. R., Frederick, D. W., Pongratz, R. L., Zhao, X., Moeckel, G. W., Samuel, V. T., Whaley, J. M., et al. (2011) · Diabetes · doi:10.2337/db10-1328 · Cited by 221
Turner, R. J., & Moran, A. (1982) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1982.242.4.f406 · Cited by 221
Salem, R. M., Todd, J. N., Sandholm, N., Cole, J. B., Chen, W., Andrews, D. C., Pezzolesi, M. G., McKeigue, P., Hiraki, L. T., Qiu, C., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019030218 · Cited by 216
The role of protein kinase C activation in diabetic nephropathy
Noh, H., & King, G. L. (2007) · Kidney International · doi:10.1038/sj.ki.5002386 · Cited by 214
Papademetriou, V., Lovato, L., Doumas, M., Nylen, E., Mottl, A., Cohen, R. M., Applegate, W. B., Puntakee, Z., Yale, J. F., & Cushman, W. C. (2015) · Kidney International · doi:10.1038/ki.2014.296 · Cited by 210
Tubular changes in early diabetic nephropathy
Thomas, M. C., Burns, W. C., & Cooper, M. E. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2005.01.008 · Cited by 209
Mechanisms of Disease: the hypoxic tubular hypothesis of diabetic nephropathy
Singh, D. K., Winocour, P. H., & Farrington, K. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph0757 · Cited by 202
Pruijm, M., Milani, B., Pivin, E., Podhajska, A., Vogt, B., Stuber, M., & Burnier, M. (2018) · Kidney International · doi:10.1016/j.kint.2017.10.020 · Cited by 200
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus
Song, P., Ōnishi, A., Koepsell, H., & Vallon, V. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1168808 · Cited by 196
Self-citationA Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
van Zuydam, N. R., Ahlqvist, E., Sandholm, N., Deshmukh, H., Rayner, N. W., Abdalla, M., Ladenvall, C., Ziemek, D., Fauman, E. B., Robertson, N. R., et al. (2018) · Diabetes · doi:10.2337/db17-0914 · Cited by 196
Sabolić, I., Vrhovac, I., Balen, D., Gerasimova, M., Rose, M. A., Breljak, D., Ljubojević, M., Brzica, H., Sebastiani, A., Thal, S. C., et al. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00450.2011 · Cited by 193
Self-citationGembardt, F., Bartaun, C., Jarzebska, N., Mayoux, E., Todorov, V., Hohenstein, B., & Hugo, C. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00145.2014 · Cited by 192
Freitas, H. S., Anhê, G. F., Melo, K., Okamoto, M. M., Oliveira‐Souza, M., Bordin, S. A., & Machado, U. F. (2007) · Endocrinology · doi:10.1210/en.2007-1088 · Cited by 192
Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy
Lee, Y. H., Kim, S. H., Kang, J. M., Heo, J. H., Kim, D.-J., Park, S. H., Sung, M. J., Kim, J., Oh, J., Yang, D. H., et al. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00565.2018 · Cited by 192
EFFECT OF DIABETES AND INSULIN ON THE MAXIMUM CAPACITY OF THE RENAL TUBULES TO REABSORB GLUCOSE 1
Färber, S. J., Berger, E. Y., & Earle, D. P. (1951) · Journal of Clinical Investigation · doi:10.1172/jci102424 · Cited by 188
Acute kidney injury in patients on SGLT2 inhibitors: a propensity-matched analysis
Nadkarni, G. N., Ferrandino, R., Chang, A., Surapaneni, A., Chauhan, K., Poojary, P., Saha, A., Ferket, B., Grams, M. E., & Coca, S. G. (2017) · Diabetes Care · doi:10.2337/dc17-1011 · Cited by 188
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
CEFALO, C. M. A., Cinti, F., Moffa, S., Impronta, F., Sorice, G. P., Mezza, T., Pontecorvi, A., & Giaccari, A. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0828-y · Cited by 188
SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1
Novikov, A., Fu, Y., Huang, W., Freeman, B., Patel, R., van Ginkel, C., Koepsell, H., Busslinger, M., Onishi, A., Nespoux, J., et al. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00462.2018 · Cited by 186
Self-citationPessoa, T. D., Campos, L. C. G., Carraro-Lacroix, L., Girardi, A. C. C., & Malnic, G. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060588 · Cited by 184
SGLT2 inhibition and kidney protection
Nespoux, J., & Vallon, V. (2018) · Clinical Science · doi:10.1042/cs20171298 · Cited by 182
Self-citationAdenosine formed by 5′-nucleotidase mediates tubuloglomerular feedback
Thomson, S. C., Bao, D., Deng, A., & Vallon, V. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8761 · Cited by 179
Self-citationLytvyn, Y., Škrtić, M., Yang, G. K., Yip, P. S. F., Perkins, B. A., & Cherney, D. Z. I. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00555.2014 · Cited by 173
Toyoki, D., Shibata, S., Kuribayashi‐Okuma, E., Xu, N., Ishizawa, K., Hosoyamada, M., & Uchida, S. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00012.2017 · Cited by 169
Marks, J., Carvou, N., Debnam, E. S., Srai, S. K., & Unwin, R. J. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.046268 · Cited by 166
Balen, D., Ljubojević, M., Breljak, D., Brzica, H., Z̆lender, V., Koepsell, H., & Sabolić, I. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00180.2008 · Cited by 166
Glomerular Hyperfiltration and the Salt Paradox in Early Type 1 Diabetes Mellitus
Vallon, V., Blantz, R. C., & Thomson, S. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051700.07403.27 · Cited by 166
Self-citationImproved glycemic control in mice lacking Sglt1 and Sglt2
Powell, D. R., DaCosta, C. M., Gay, J. P., Ding, Z., Smith, M. G., Greer, J., Doree, D. D., Jeter-Jones, S. L., Mseeh, F., Rodriguez, L. A., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00439.2012 · Cited by 161
Regulation of Renal Sodium Transporters during Severe Inflammation
Schmidt, C. G., Höcherl, K., Schweda, F., Kurtz, A., & Bucher, M. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050454 · Cited by 160
Inflammatory signaling and cellular senescence
Ren, J., Pan, J., Lu, Y.-P., Sun, P., & Han, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.011 · Cited by 153
Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury.
Phillips, A. O., & Steadman, R. (2002) · PubMed · doi:10.14670/hh-17.247 · Cited by 146
Differences in active and passive glucose transport along the proximal nephron
Barfuss, D. W., & Schafer, J. A. (1981) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1981.241.3.f322 · Cited by 144
Modeling oxygen consumption in the proximal tubule: effects of NHE and SGLT2 inhibition
Layton, A. T., Vallon, V., & Edwards, A. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00007.2015 · Cited by 142
Self-citationLayton, A. T., Vallon, V., & Edwards, A. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00543.2015 · Cited by 141
Self-citationJAK inhibition in the treatment of diabetic kidney disease
Brosius, F. C., Tuttle, K. R., & Kretzler, M. (2016) · Diabetologia · doi:10.1007/s00125-016-4021-5 · Cited by 140
Layton, A. T., & Vallon, V. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00551.2017 · Cited by 132
Self-citationHan, H. J., Lee, Y. J., Park, S. H., Lee, J., & Taub, M. L. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00327.2004 · Cited by 130
The renal hemodynamic basis of diabetic nephropathy.
Gt, O., & Th, H. (1997) · PubMed · Cited by 130
Insulin's impact on renal sodium transport and blood pressure in health, obesity, and diabetes
Tiwari, S., Riazi, S., & ECELBARGER, C. A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00149.2007 · Cited by 128
Regulation of the human Na+-dependent glucose cotransporter hSGLT2
Ghezzi, C., & Wright, E. M. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00115.2012 · Cited by 124
Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO
Tolins, J. P., Shultz, P. J., Raij, L. R., Brown, D. M., & Mauer, S. M. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.265.6.f886 · Cited by 123
Effect of Puberty on Markers of Glomerular Hypertrophy and Hypertension in IDDM
Lawson, M. L., Sochett, E. B., Chait, P. G., Balfe, J. W., & Daneman, D. (1996) · Diabetes · doi:10.2337/diab.45.1.51 · Cited by 119
Tubular sodium handling and tubuloglomerular feedback in experimental diabetes mellitus
Pollock, C. A., LAWRENCE, J. R., & Field, M. J. (1991) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1991.260.6.f946 · Cited by 119
Cannon, C. P., Perkovic, V., Agarwal, R., Baldassarre, J., Bakris, G., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Heerspink, H. J. L., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044359 · Cited by 117
Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats
Dominguez, J. H., Camp, K., Maianu, L., Feister, H. A., & Garvey, W. T. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.2.f283 · Cited by 113
The role of tubular injury in diabetic nephropathy
Magri, C. J., & Fava, S. (2009) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.12.012 · Cited by 112
Vallon, V., Blantz, R. C., & Thomson, S. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.269.6.f876 · Cited by 112
Self-citationKomers, R., Lindsley, J. N., Oyama, T., Allison, K. M., & Anderson, S. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f573 · Cited by 107
MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2
Coady, M. J., El Tarazi, A., Santer, R., Bissonnette, P., Sasseville, L. J., Calado, J., Lussier, Y., Dumayne, C., Bichet, D. G., & Lapointe, J.-Y. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015111282 · Cited by 106
Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes
Hannedouche, T. P., Delgado, A. G., Gnionsahe, D. A., Boîtard, C., Lacour, B., & Grünfeld, J. (1990) · Kidney International · doi:10.1038/ki.1990.95 · Cited by 104
Zhang, J., Wei, J., Jiang, S., Xu, L., Wang, L., Cheng, F., Buggs, J., Koepsell, H., Vallon, V., & Liu, R. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018080844 · Cited by 103
Self-citationWolf, G., Schroeder, R., Ziyadeh, F. N., Thaiss, F., Zahner, G., & Stahl, R. A. K. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.3.f348 · Cited by 102
Zerbini, G., Bonfanti, R., Meschi, F., Bognetti, E., Paesano, P. L., Gianolli, L., Querques, M., Maestroni, A., Calori, G., Maschio, A. D., et al. (2006) · Diabetes · doi:10.2337/db06-0592 · Cited by 101
Control of renal hemodynamics in hyperglycemia: possible role of tubuloglomerular feedback
Woods, L. L., Mizelle, H. L., & Hall, J. E. (1987) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1987.252.1.f65 · Cited by 100
Hallow, K. M., Gebremichael, Y., Helmlinger, G., & Vallon, V. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00497.2016 · Cited by 98
Self-citationPKC‐β and PKC‐ζ mediate opposing effects on proximal tubule Na+,K+‐ATPase activity
Efendiev, R., Bertorello, A. M., & Pedemonte, C. H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00925-4 · Cited by 96
Meier, M., Park, J.-K., Overheu, D., Kirsch, T., Lindschau, C., Gueler, F., Leitges, M., Menne, J., & Haller, H. G. (2007) · Diabetes · doi:10.2337/db06-0891 · Cited by 96
Lin, R., Murtazina, R., Cha, B., Chakraborty, M., Sarker, R. I., Chen, T., Lin, Z., Hogema, B. M., de Jonge, H. R., Seidler, U. E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.10.042 · Cited by 95
Feedback Control of Glomerular Vascular Tone in Neuronal Nitric Oxide Synthase Knockout Mice
Vallon, V., Traynor, T. R., Barajas, L., Huang, Y. G., BRIGGS, J. P., & SCHNERMANN, J. D. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1281599 · Cited by 95
Self-citationTransition of kidney tubule cells to a senescent phenotype in early experimental diabetes
Satriano, J., Mansoury, H., Deng, A., Sharma, K., Vallon, V., Blantz, R. C., & Thomson, S. C. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00096.2010 · Cited by 93
Self-citationVallon, V., Schroth, J., Satriano, J. A., Blantz, R. C., Thomson, S. C., & Rieg, T. (2009) · Nephron Physiology · doi:10.1159/000208211 · Cited by 90
Self-citationLack of A1 Adenosine Receptors Augments Diabetic Hyperfiltration and Glomerular Injury
Faulhaber‐Walter, R., Chen, L., Oppermann, M., Kim, S. M., Huang, Y. G., Hiramatsu, N., Mizel, D. E., Kajiyama, H., Zerfas, P. M., Briggs, J. P., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060721 · Cited by 90
Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats
Vallon, V., Wead, L. M., & Blantz, R. C. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v5101761 · Cited by 86
Self-citationOverexpression of GLUT2 gene in renal proximal tubules of diabetic Zucker rats.
Kamran, M., Peterson, R. G., & Dominguez, J. H. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v86943 · Cited by 86
Role of Growth Factors in Diabetic Kidney Disease
Chiarelli, F., Gaspari, S., & Marcovecchio, M. L. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0029-1220752 · Cited by 85
S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy
Chen, J., Chen, J., Thomas, G., Kozma, S. C., & Harris, R. C. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00186.2009 · Cited by 84
MacDonald, F., Peel, J. E., Jones, H. B., Mayers, R. M., Westgate, L., Whaley, J. M., & Poucher, S. M. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01291.x · Cited by 83
Chin, E., Zamah, A. M., Landau, D., Grønbæk, H., Flyvbjerg, A., LeRoith, D., & Bondy, C. A. (1997) · Endocrinology · doi:10.1210/endo.138.3.5015 · Cited by 81
Vervoort, G., Veldman, B. A. J., Berden, J. H. M., Smits, P., & Wetzels, J. F. M. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01497.x · Cited by 81
The effect of dapagliflozin on renal function in patients with type 2 diabetes
Kohan, D. E., Fioretto, P., Johnsson, K. M., Parikh, S. J., Ptaszynska, A., & Ying, L. (2016) · Journal of Nephrology · doi:10.1007/s40620-016-0261-1 · Cited by 78
The Tuberin/mTOR Pathway Promotes Apoptosis of Tubular Epithelial Cells in Diabetes
Velagapudi, C., Bhandari, B. S., Abboud‐Werner, S. L., Simone, S., Abboud, H. E., & Habib, S. L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040352 · Cited by 77
Effects of SGLT2 inhibitors on cardiovascular outcomes
Foote, C., Perkovic, V., & Neal, B. C. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112441190 · Cited by 76
Vallon, V., Huang, D., Deng, A., Richter, K., Blantz, R. C., & Thomson, S. C. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000016441.41118.57 · Cited by 75
Self-citationHinden, L., Udi, S., Drori, A., Gammal, A., Nemirovski, A., Hadar, R., Baraghithy, S., Permyakova, A., Geron, M., Cohen, M., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017040371 · Cited by 75
How Do Kidneys Adapt to a Deficit or Loss in Nephron Number?
Fattah, H., Layton, A. T., & Vallon, V. (2019) · Physiology · doi:10.1152/physiol.00052.2018 · Cited by 74
Self-citationFlow-dependent transport in a mathematical model of rat proximal tubule
Weinstein, A. M., Weinbaum, S., Duan, Y., Du, Z., Yan, Q., & Wang, T. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00392.2006 · Cited by 73
Thomson, S. C., Bachmann, S., Bostanjoglo, M., ECELBARGER, C. A., Peterson, Ö. W., Schwartz, D., Bao, D., & Blantz, R. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5156 · Cited by 72
Self-citationRenal responses to sodium restriction in patients with early diabetes mellitus.
Miller, J. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v85749 · Cited by 72
Effect of renal tubule-specific knockdown of the Na+/H+exchanger NHE3 in Akita diabetic mice
Onishi, A., Fu, Y., Darshi, M., Crespo-Masip, M., Huang, W., Song, P., Patel, R., Kim, Y. C., Nespoux, J., Freeman, B., et al. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00497.2018 · Cited by 71
Self-citationDiabetic Nephropathy: Metabolic versus hemodynamic considerations
Hostetter, T. H. (1992) · Diabetes Care · doi:10.2337/diacare.15.9.1205 · Cited by 68
Macula Densa Nitric Oxide Synthase 1β Protects against Salt-Sensitive Hypertension
Lü, Y., Wei, J., Stec, D. E., Roman, R. J., Ge, Y. C., Cheng, L., Liu, E. Y., Zhang, J., Hansen, P., Fan, F., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050515 · Cited by 68
TGF-β1 Induces the Cyclin-Dependent Kinase Inhibitor p27Kip1 mRNA and Protein in Murine B Cells
Kamesaki, H., Nishizawa, K., Michaud, G. Y., Cossman, J., & Kiyono, T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.770 · Cited by 68
TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki, H., Nishizawa, K., Michaud, G. Y., Cossman, J., & Kiyono, T. (1998) · PubMed · Cited by 67
Renal epithelium regulates erythropoiesis via HIF-dependent suppression of erythropoietin
Farsijani, N., Liu, Q., Kobayashi, H., Davidoff, O., Sha, F., Fandrey, J., Ikizler, T. A., O'Connor, P. M., & Haase, V. H. (2016) · Journal of Clinical Investigation · doi:10.1172/jci74997 · Cited by 67
Increased intracellular pH at the macula densa activates nNOS during tubuloglomerular feedback
Liu, R., Carretero, O. A., Ren, Y., & Garvin, J. L. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00282.x · Cited by 66
Sällström, J., Carlsson, P. ‐., Fredholm, B. B., Larsson, E., Persson, A. E. G., & Palm, F. (2007) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01705.x · Cited by 66
Song, P., Huang, W., Ōnishi, A., Patel, R., Kim, Y. C., van Ginkel, C., Fu, Y., Freeman, B., Koepsell, H., Thomson, S. C., et al. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00120.2019 · Cited by 66
Self-citationRenal Effects of Sodium-Glucose Co-Transporter Inhibitors
Thomson, S. C., & Vallon, V. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.10.027 · Cited by 66
Self-citationLarge kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease
Rigalleau, V., Garcia, M., Lasseur, C., Laurent, F., Montaudon, M., Raffaitin, C., Barthe, N., Beauvieux, M.-C., Vendrely, B., Chauveau, P., et al. (2010) · BMC Nephrology · doi:10.1186/1471-2369-11-3 · Cited by 65
Hansen, H. H., Jelsing, J., Hansen, C. F., Hansen, G., Vrang, N., Mark, M., Klein, T., & Mayoux, E. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213454 · Cited by 63
Pruijm, M., Wuerzner, G., Maillard, M., Bovet, P., Renaud, C., Bochud, M., & Burnier, M. (2010) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfq008 · Cited by 63
Early diabetes as a model for testing the regulation of juxtaglomerular NOS I
Thomson, S. C., Deng, A., Komine, N., Hammes, J. S., Blantz, R. C., & Gabbai, F. B. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00340.2003 · Cited by 62
Self-citationUnmasking a sustained negative effect of SGLT2 inhibition on body fluid volume in the rat
Masuda, T., Watanabe, Y., Fukuda, K., Watanabe, M., Ōnishi, A., Ohara, K., Imai, T., Koepsell, H., Muto, S., Vallon, V., et al. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00143.2018 · Cited by 62
Self-citationGLUT1 Regulation of the Pro-Sclerotic Mediators of Diabetic Nephropathy
Heilig, C. W., Deb, D. K., Abdul, A., Riaz, H., James, L. R., Salameh, J., & Nahman, N. S. (2013) · American Journal of Nephrology · doi:10.1159/000351989 · Cited by 61
Renal effects of canagliflozin in type 2 diabetes mellitus
Perkovic, V., Jardine, M., Vijapurkar, U., & Meininger, G. E. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1092128 · Cited by 58
Phillips, A. O., Steadman, R., Morrisey, K., & Williams, J. D. (1997) · Europe PMC (PubMed Central) · Cited by 57
SGLT2 inhibitors act from the extracellular surface of the cell membrane
Ghezzi, C., Hirayama, B. A., Gorraitz, E., Loo, D. D. F., Liang, Y. T., & Wright, E. M. (2014) · Physiological Reports · doi:10.14814/phy2.12058 · Cited by 57
On the prognosis of IDDM patients with large kidneys
Baumgartl, H.-J., Sigl, G., Banholzer, P., Haslbeck, M., & Standl, E. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.3.630 · Cited by 54
Tubular Transport in Acute Kidney Injury: Relevance for Diagnosis, Prognosis and Intervention
Vallon, V. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000446448 · Cited by 53
Self-citationSims, H., Smith, K. H., Bramlage, P., & Minguet, J. (2018) · Diabetic Medicine · doi:10.1111/dme.13645 · Cited by 53
Osorio‐Alonso, H., Bautista, R., Rı́os, A., Franco, M., Santamaría, J., & Escalante, B. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.09.006 · Cited by 52
Salt-sensitive splice variant of nNOS expressed in the macula densa cells
Lu, D., Fu, Y., LOPEZ‐RUIZ, A. F., Zhang, R., Juncos, R., Liu, H., Manning, R. D., Juncos, L. A., & Liu, R. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00650.2009 · Cited by 51
Zapata‐Morales, J. R., Galicia-Cruz, O. G., Franco, M., & Martínez-Morales, F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.526814 · Cited by 50
Sokolovska, J., Isajevs, S., Sugoka, O., Sharipova, J., Ļauberte, L., Svirina, D., Rostoka, E., Sjakste, T., Kalvinsh, I., & Sjakste, N. (2010) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2010.494672 · Cited by 48
Proximal glomerulo-tubular balance in patients with Type 1 (insulin-dependent) diabetes mellitus
Brøchner‐Mortensen, J., Støckel, M., Sørensen, P. J., Nielsen, A. H., & Ditzel, J. (1984) · Diabetologia · doi:10.1007/bf00273804 · Cited by 47
ROLE OF NITRIC OXIDE IN TUBULOGLOMERULAR FEEDBACK: EFFECTS OF DIETARY SALT
Welch, W. J., & Wilcox, C. S. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb02095.x · Cited by 45
Effect of chronic salt loading on kidney function in early and established diabetes mellitus in rats
Vallon, V., Kirschenmann, D., Wead, L. M., Lortie, M. J., Satriano, J. A., Blantz, R. C., & Thomson, S. C. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90061-5 · Cited by 45
Self-citationPossible mechanism of efferent arteriole (Ef-Art) tubuloglomerular feedback
Ren, Y., Garvin, J. L., Liu, R., & Carretero, O. A. (2007) · Kidney International · doi:10.1038/sj.ki.5002161 · Cited by 44
Dipyridamole prevents diabetes-induced alterations of kidney function in rats
Vallon, V., & Oßwald, H. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169840 · Cited by 44
Self-citationSLC2A2 gene expression in kidney of diabetic rats is regulated by HNF-1α and HNF-3β
Freitas, H. S., Schaan, B. D., David-Silva, A., Silva, R. S., Okamoto, M. M., Alves-Wagner, A. B., Mori, R. C. T., & Machado, U. F. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.014 · Cited by 42
Increased Proximal Tubular Sodium Reabsorption in Hypertensive Patients with Type 2 Diabetes
Mbanya, J. C., Thomas, T. H., Taylor, R., Alberti, K. G. M. M., & Wilkinson, R. (1989) · Diabetic Medicine · doi:10.1111/j.1464-5491.1989.tb01238.x · Cited by 40
Organic anion transporter OAT3 enhances the glucosuric effect of the SGLT2 inhibitor empagliflozin
Fu, Y., Breljak, D., Ōnishi, A., Batz, F., Patel, R., Huang, W., Song, P., Freeman, B., Mayoux, E., Koepsell, H., et al. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00503.2017 · Cited by 40
Self-citationNespoux, J., Patel, R., Hudkins, K. L., Huang, W., Freeman, B., Kim, Y. C., Koepsell, H., Alpers, C. E., & Vallon, V. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00111.2019 · Cited by 40
Self-citationIshizawa, K., Wang, Q. L., Li, J., Xu, N., Nemoto, Y., Morimoto, C., Fujii, W., Tamura, Y., Fujigaki, Y., Tsukamoto, K., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018070703 · Cited by 37
Goestemeyer, A., Marks, J., Srai, S. K., Debnam, E. S., & Unwin, R. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0778-x · Cited by 36
Do Tubular Changes in the Diabetic Kidney Affect the Susceptibility to Acute Kidney Injury?
Vallon, V. (2014) · Nephron Clinical Practice · doi:10.1159/000363554 · Cited by 34
Self-citationKidokoro, K., Sogawa, Y., Cherney, D., Kulasingam, V., Nagasu, H., Satoh, M., Sasaki, T., & Kashihara, N. (2018) · Diabetes · doi:10.2337/db18-89-or · Cited by 34
Pedersen, S. B., Flyvbjerg, A., & Richelsen, B. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.2.c453 · Cited by 33
Preventing and Treating Heart Failure with Sodium-Glucose Co-Transporter 2 Inhibitors
Vaduganathan, M., & Januzzi, J. L. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.10.026 · Cited by 33
Huang, J., Chuang, L., Guh, J., & Huang, Y.-J. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp134 · Cited by 31
Wang, X., Chandrashekar, K., Wang, L., Lai, E. Y., Wei, J., Zhang, G., Wang, S., Zhang, J., Juncos, L. A., & Liu, R. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.07032 · Cited by 31
Influence of sex on hyperfiltration in patients with uncomplicated type 1 diabetes
Škrtić, M., Lytvyn, Y., Bjornstad, P., Reich, H. N., Scholey, J. W., Yip, P. S. F., Sochett, E. B., Perkins, B. A., & Cherney, D. Z. I. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00357.2016 · Cited by 29
Renal hypertrophy in experimental diabetes: Some functional aspects
Seyer‐Hansen, K. (1987) · Journal of Diabetes and its Complications · doi:10.1016/s0891-6632(87)80018-1 · Cited by 27
Lau, C., Sudbury, I., Thomson, M., Howard, P. L., Magil, A. B., & Cupples, W. A. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90731.2008 · Cited by 24
Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes
Ekinci, E. I., Clarke, S., Thomas, M. C., Cheong, K., Macisaak, R. J., & Lerums, G. (2011) · Obesity and metabolism · doi:10.14341/2071-8713-4842 · Cited by 21
Osmotic diuresis in a mathematical model of the rat proximal tubule
Weinstein, A. M. (1986) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1986.250.5.f874 · Cited by 21
Renal sodium metabolism in relation to hypertension in diabetes.
Ditzel, J., Lervang, H. H., & Brøchner‐Mortensen, J. (1989) · PubMed · Cited by 19
Research works printed but not linked: 1
- Fu, Y., Gerasimova, M., Mayoux, E., Masuda, T. & Vallon, V. SGLT2 inhibitor empagliflozin increases renal NHE3 phosphorylation in diabetic Akita mice: possible implications for the prevention of glomerular hyperfiltration. Diabetes 63, (supplement 1), A132 (2014).
Cited by
Sorted by citations
Molecular mechanisms and therapeutic targets for diabetic kidney disease
Tuttle, K. R., Agarwal, R., Alpers, C. E., Bakris, G. L., Brosius, F. C., Kolkhof, P., & Uribarri, J. (2022) · Kidney International · doi:10.1016/j.kint.2022.05.012 · Cited by 724
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
DeFronzo, R. A., Reeves, W. B., & Awad, A. S. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00393-8 · Cited by 627
Kopp, J. B., Anders, H., Suszták, K., Podestà, M. A., Remuzzi, G., Hildebrandt, F., & Romagnani, P. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0196-7 · Cited by 570
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 573
Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function
Vallon, V., & Verma, S. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-095920 · Cited by 556
Self-citation
Metadata
- Authors
- Vallon, V., & Thomson, S. C.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Vallon, Volker
- Venue
- Nature Reviews Nephrology
- Published
- 2020-03-09
- Volume
- 16
- Issue
- 6
- Pages
- 317-336
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- PMC
- PMC7242158
- OpenAlex
- W3009930262
- Cited by
- 465
- References
- 211
- Citations by year
- 2026: 80 · 2025: 75 · 2024: 79 · 2023: 70 · 2022: 79 · 2021: 55 · 2020: 24
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Nephrology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (1rf1ag061296-01a1)
- National Institute on Aging (RF1-AG061296)
- National Heart, Lung, and Blood Institute (R01HL142814)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079337, R01DK106102, R01DK112042)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetic nephropathy, glomerular hyperfiltration, tubuloglomerular feedback, SGLT2, SGLT1, proximal tubular reabsorption, macula densa, nitric oxide, renal fibrosis, SGLT2 inhibitors, glomerular filtration rate
- MeSH terms
- Sodium-Glucose Transporter 2 Inhibitors, Chlorides, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Fibrosis, Glomerular Filtration Rate, Glucose, Humans, Hypertrophy, Inflammation, Kidney Glomerulus, Kidney Tubules, Nephrons, Nitric Oxide, Sodium, Cellular Senescence, Sodium-Glucose Transporter 1, Sodium-Glucose Transporter 2, Glomerular Filtration Barrier, Renal Reabsorption
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
